NeuroRx
  • Home
  • About Us
  • Covid-19
  • NRX-100/101
  • News
  • Contact
  • Home
  • News
  • Broadcasts
  • Prof Jonathan Javitt joins i24NEWS – FDA Grants Continuation of COVID-19 Trial

Prof Jonathan Javitt joins i24NEWS – FDA Grants Continuation of COVID-19 Trial

Broadcasts
Clinical Trials Covid-19 i24 News

Share:

Categories

  • Broadcasts
  • News
  • Press releases

Tags

ARDS Aviptadil Big Rock Partners Bipolar Depression Clinical Trials Covid-19 Emergency Use Expanded Access Fast Track FDA Houston I-Spy i24 News NASDAQ NRX-100/101 NRXP Orphan Drug Designation Respiratory Failure RLF-100 VIP Zysami

Related Posts

Press releases

NeuroRx, Relief, and Quantum Leap announce the inclusion of ZYESAMI™ (RLF-100™: aviptadil) in the I-SPY COVID-19 Trial

Read more
News

Which COVID-19 treatments are showing promise? A list of potential drugs

Read more
Press releases

BIG ROCK PARTNERS ACQUISITION CORP. ANNOUNCES MERGER WITH NEURORX, INC.

Read more

Developing innovative therapies for high-mortality unmet needs.

Company Info

  • About Us
  • RLF-100
  • NRX 100/101

Learn More

  • USA-Licensed Physicians
  • Investors
© 2020 NeuroRx, Inc.